Chargement en cours...
How I treat refractory chronic graft-versus-host disease
Approximately 35% to 50% of patients otherwise cured of hematologic malignancies after allogeneic hematopoietic stem cell transplantation will develop the pleomorphic autoimmune-like syndrome known as chronic graft-versus-host disease (cGVHD). Since in 2005, National Institutes of Health (NIH) conse...
Enregistré dans:
| Publié dans: | Blood |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6418480/ https://ncbi.nlm.nih.gov/pubmed/30674472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-04-785899 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|